Trafa Pharmaceutical Inc. – FDA Inspection, Jun 25, 2026

Record Details

This FDA Inspection record concerns Trafa Pharmaceutical Inc., with an inspection on June 25, 2026, issued by the New England District Office, covering foods & cosmetics.

Company: Trafa Pharmaceutical Inc.
Inspection Date: June 25, 2026
Product Type: Foods & Cosmetics
Office: New England District Office
People: Brenna L. MacDowell (Issuing Officer)
Dana A. Razzano (FDA Associated Person)
Kleever N. Soto-Santiago (Issuing Officer)
Nasser Yazdani (Issuing Officer)

View Company Profile

ID · c6467e2d-d568-4b29-9e87-04afbe3bf51b

Inspection Facts

Inspection number: 1324126
FDA center: Foods & Cosmetics
Project area: Foodborne Biological Hazards
Outcome: Form 483 issued

FDA Citations

21 CFR 111.15(b)Physical plant - clean and sanitary
21 CFR 117.93Storage and Distribution
21 CFR 1.225Not registered

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Trafa Pharmaceutical Inc.

FDA Inspection

Trafa Pharmaceutical Inc.June 25, 2026